M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia

Phase 2

Terminated

Conditions: Leukemia

Interventions: Drug: Etanercept

First Posted Date: 2007-07-31

Last Posted Date: 2012-08-07

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 1

Registration Number: NCT00509600

Locations: 🇺🇸
UT MD . Anderson Cancer Center, Houston, Texas, United States

Phase I Trial of ZIO-101 in Patients With Solid Tumors

Phase 1

Completed

Conditions: Solid Tumors

Interventions: Drug: ZIO-101

First Posted Date: 2007-07-31

Last Posted Date: 2012-08-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 47

Registration Number: NCT00509782

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM

Phase 1

Terminated

Conditions: Glioblastoma Multiforme

Interventions: Drug: Temodar (Temozolomide)
Dietary Supplement: Hominex-2

First Posted Date: 2007-07-30

Last Posted Date: 2012-01-16

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 18

Registration Number: NCT00508456

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

RTA 402 in Advanced Solid Tumors or Lymphoid Malignancies

Phase 1

Completed

Conditions: Lymphoid Malignancies
Solid Tumors

Interventions: Drug: RTA 402

First Posted Date: 2007-07-30

Last Posted Date: 2012-07-30

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 21

Registration Number: NCT00508807

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Iressa Study in Patients With Salivary Gland Cancer

Phase 2

Completed

Conditions: Salivary Gland Cancer

Interventions: Drug: Gefitinib

First Posted Date: 2007-07-30

Last Posted Date: 2017-11-24

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 37

Registration Number: NCT00509002

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy

Completed

Conditions: Endometrial Cancer
Cervical Cancer
Uterine Cancer

Interventions: Radiation: Intensity Modulated Radiotherapy (IMRT)
Procedure: CT Scan

First Posted Date: 2007-07-30

Last Posted Date: 2017-09-12

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 24

Registration Number: NCT00508703

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Folfox-B Study for Patients With Colorectal Liver Metastases

Phase 2

Terminated

Conditions: Colorectal Liver Metastases

Interventions: Drug: 5-Fluorouracil
Drug: Bevacizumab
Drug: Leucovorin
Drug: Oxaliplatin

First Posted Date: 2007-07-30

Last Posted Date: 2012-08-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 2

Registration Number: NCT00508872

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Effects of Yoga in Breast Cancer Patients

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Yoga Group
Behavioral: Stretching Control Group
Behavioral: Waitlist Control Group
Other: Questionnaire

First Posted Date: 2007-07-30

Last Posted Date: 2022-09-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 191

Registration Number: NCT00508794

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Screening for Gynecologic Cancers in Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Patients

Completed

Conditions: Colon Cancer

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-07-30

Last Posted Date: 2016-03-11

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 93

Registration Number: NCT00508846

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Registry for Women Who Are At Risk Or May Have Lynch Syndrome

Completed

Conditions: Hereditary Nonpolyposis Colorectal Cancer
Lynch Syndrome

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-07-30

Last Posted Date: 2024-08-09

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 323

Registration Number: NCT00508573

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy